The use of an intracoronary hemodynamic technique, such as FRACTIONAL FLOW RESERVE (FFR), to determine the severity of a stenosis, can help when deciding whether to perform percutaneous coronary ...

As data bandwidths escalate, the conventional-PCI shared-bus technology is too slow for many high-performance I/O applications. PCI Express promises to extend the life of PCI by providing a low-cost, ...

NEC is developing a system that can extend the conventional PCI Express interface found in most PCs and servers over standard Ethernet to distances of 2 kilometers or more. ExpEther, as the company ...

ORLANDO – November 4, 2021 – The FAVOR III China trial found that lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed physiologic measurement quantitative ...

Do PCI 2.1/2.2 slots support both 5v and 3.3v signaling?<BR><BR>I was under the assumption that all conventional PCI devices were 5v only, but am now extremely confused at which specs support which ...

AWANS, Belgium -- Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO® therapy compared with ...

Conventional PCI and PCI-X computer slots have four supply voltages available: +12, +5, +3.3, and ­12 V. PCI and PCI-X cards rely on +5 V and +3.3 V for most of the power and are limited to 500 mA of ...

Primary percutaneous coronary intervention (PCI) is the standard treatment for ST-segment elevation myocardial infarction (STEMI). Although PCI is effective at opening the infarct-related artery, ...

The multicentre DANAMI-3-DEFER trial in Denmark (March 2011 to February 2014) found no significant clinical benefits of deferred stenting over conventional PCI with immediate stenting for patients ...

Subhash Banerjee, MD (VA North Texas Health Care System & UT Southwestern Medical Center, Dallas), who presented the results of the PREMIER trial in a featured clinical research session at the annual ...

AWANS, Belgium--(BUSINESS WIRE)--Miracor Medical SA (Miracor Medical) today announced the initiation and first patient enrollment in the PICSO-AMI-I study to evaluate the benefits of PiCSO ® therapy ...